ASP Isotopes Inc. Common ... (ASPI)
4.20
-0.53 (-11.21%)
At close: Mar 28, 2025, 3:59 PM
4.20
0.12%
After-hours: Mar 28, 2025, 06:39 PM EDT
Company Description
ASP Isotopes Inc., a pre-commercial stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes.
It develops Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28.
The company also Uranium-235, an isotope of uranium for carbon-free energy industry.
ASP Isotopes Inc. was incorporated in 2021 and is based in Boca Raton, Florida.
ASP Isotopes Inc. Common Stock

Country | United States |
IPO Date | Nov 10, 2022 |
Industry | Chemicals |
Sector | Basic Materials |
Employees | 76 |
CEO | Paul Elliot Mann C.F.A. |
Contact Details
Address: 433 Plaza Real Boca Raton, Florida United States | |
Website | aspisotopes.com |
Stock Details
Ticker Symbol | ASPI |
Exchange | NASDAQ |
Fiscal Year | n/a |
Reporting Currency | USD |
CIK Code | 0001921865 |
CUSIP Number | 00218A105 |
ISIN Number | US00218A1051 |
Employer ID | 87-2618235 |
SIC Code | 2890 |
Key Executives
Name | Position |
---|---|
Dr. Gerdus Kemp M.D., Ph.D. | Medical Director & Chief Executive Officer of Pet Labs |
Paul Elliot Mann C.F.A. | President, Chief Executive Officer & Executive Chairman |
Dr. Hendrik Strydom B. Sc, M. Sc, Ph.D. | Chief Technology Officer & Director |
Heather Kiessling | Chief Financial Officer |
Robert Ainscow | Chief Operating Officer |
Dr. Xandra van Heerden Ph.D. | Head of Research & Development |
Hendrik T. van Wyk | Head of Engineering |
William Eden M.B.E. | Global Head of HR & Director UK Nuclear Operations |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 27, 2025 | 8-K | Current Report |
Feb 26, 2025 | 8-K | Current Report |
Feb 18, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 18, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 14, 2025 | SCHEDULE 13G | Filing |
Feb 14, 2025 | 5 | Filing |
Feb 14, 2025 | 5 | Filing |
Feb 12, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Feb 04, 2025 | SCHEDULE 13G | Filing |
Jan 13, 2025 | 8-K | Current Report |